Viome’s Oral Health Pro System Detects Early Signs of Disease and Oral & Throat Cancer

Viome’s Oral Health Pro System Detects Early Signs of Disease and Oral & Throat Cancer. Image: © Viome Life Sciences

Viome Life Sciences has released a new at-home testing kit that is available for both patients and dental professionals called Oral Health Pro™. This test uses a patient’s saliva to measure gene expressions and cells that are present there, then analyzing results for a variety of aspects, including markers for oral diseases as well as oral squamous cell carcinoma (OSCC) and oropharyngeal squamous cell carcinoma (OPSCC). Per Viome, cancer-free specificity sits at greater than or equal to 95%, OSCC sensitivity is greater than or equal to 90%, with OPSCC sensitivity also greater than or equal to 90%.

After patients are done with their saliva test, they can then send their sample to Viome’s lab where results will be measured. Viome uses a proprietary RNA sequencing technology and artificial intelligence to measure markers and molecular features associated with OSCC and OPSCC, per a press release from Viome. Along with the standard results, Viome also provides a personalized treatment plan, allowing for further collaboration between the doctor and the patient. Through Oral Health Pro’s Oral Health Scores, clinicians can see where patients may need improvement or assistance.

Patients can expect results in up to 4 weeks.